Activist 13D/13G Filings - Trevi Therapeutics, Inc. (TRVI)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-15
1:16 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
Rosalind Advisors Inc.2,499,993
4.2%
314,329increase
(+14.38%)
View
2023-02-14
4:55 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
Venrock Healthcare Capital Partners II L.P.6,312,192
9.99%
2,643,858increase
(+72.07%)
View
2023-02-14
3:45 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
Fairmount Funds Management LLC6,018,465
9.9%
2,258,955increase
(+60.09%)
View
2023-02-14
1:37 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
ARMISTICE CAPITAL LLC3,147,200
4.99%
446,401increase
(+16.53%)
View
2023-02-14
1:18 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
VIKING GLOBAL INVESTORS LP6,162,362
9.99%
177,628increase
(+2.97%)
View
2023-02-10
4:25 pm
Sale
13GTrevi Therapeutics, Inc.
TRVI
TPG GP A LLC0
0%
-4,824,883decrease
(Position Closed)
View
2023-02-10
4:00 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
Rubric Capital Management LP5,684,420
9.49%
5,684,420increase
(New Position)
View
2022-10-07
5:29 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
VIKING GLOBAL INVESTORS LP5,984,734
9.99%
5,984,734increase
(New Position)
View
2022-10-07
2:51 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
Frazier Life Sciences Public Fund L.P.6,663,590
11.4%
2,847,131increase
(+74.60%)
View
2022-04-25
5:04 pm
Purchase
13DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16 L.P.14,370,376
42.5%
6,580,526increase
(+84.48%)
View
2022-04-21
4:05 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
Venrock Healthcare Capital Partners II L.P.3,668,334
9.99%
3,668,334increase
(New Position)
View
2022-04-21
10:00 am
Purchase
13GTrevi Therapeutics, Inc.
TRVI
Fairmount Funds Management LLC3,759,510
9.9%
3,759,510increase
(New Position)
View
2022-04-18
1:32 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
Frazier Life Sciences Public Fund L.P.3,816,459
10%
3,816,459increase
(New Position)
View
2022-04-08
10:41 am
Purchase
13GTrevi Therapeutics, Inc.
TRVI
MAI Capital Management1,541,471
5%
1,541,471increase
(New Position)
View
2022-03-09
5:09 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
Rosalind Advisors Inc.2,185,664
8.5%
2,185,664increase
(New Position)
View
2022-03-09
11:18 am
Purchase
13GTrevi Therapeutics, Inc.
TRVI
Oliveira Steven Michael1,340,000
5.18%
1,340,000increase
(New Position)
View
2022-02-14
5:16 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
ARMISTICE CAPITAL LLC2,700,799
9.99%
2,700,799increase
(New Position)
View
2022-02-11
4:16 pm
Purchase
13GTrevi Therapeutics, Inc.
TRVI
TPG GP A LLC4,824,883
18.7%
4,824,883increase
(New Position)
View
2022-01-26
4:15 pm
Unchanged
13GTrevi Therapeutics, Inc.
TRVI
Lundbeckfond Invest A/S1,151,544
4.5%
0
(Unchanged)
View
2021-11-02
09:09 am
Purchase
13DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16 L.P.7,789,850
36.1%
1,851,852increase
(+31.19%)
View
Goto 0, 1, Next